Headlines about Imax (NYSE:IMAX) have trended somewhat positive this week, Accern Sentiment reports. The research group scores the sentiment of news coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Imax earned a coverage optimism score of 0.11 on Accern’s scale. Accern also gave news articles about the company an impact score of 45.1693203191387 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.
These are some of the news articles that may have effected Accern’s analysis:
- Race Heats Up Among International Operators To Open First Saudi Cinema (forbes.com)
- Nick’s SlimeZone launches in IMAX VR centers (kidscreen.com)
- IMAX And Cosmic Picture To Release IMAX® Documentary Superpower Dogs™, Presented By Mars Petcare – PR Newswire (press release) (prnewswire.com)
- Imax Corp (IMAX) Expected to Announce Quarterly Sales of $79.32 Million (americanbankingnews.com)
A number of brokerages have issued reports on IMAX. B. Riley restated a “buy” rating and set a $35.00 price objective on shares of Imax in a research report on Monday, November 20th. Wedbush set a $30.00 price objective on Imax and gave the company a “buy” rating in a research report on Monday, January 8th. Zacks Investment Research downgraded Imax from a “buy” rating to a “hold” rating in a research report on Wednesday, December 27th. ValuEngine downgraded Imax from a “hold” rating to a “sell” rating in a research report on Friday, February 2nd. Finally, JPMorgan Chase & Co. began coverage on Imax in a research report on Tuesday, February 20th. They set an “overweight” rating and a $28.00 price objective on the stock. Two investment analysts have rated the stock with a sell rating, five have issued a hold rating and six have issued a buy rating to the company’s stock. Imax presently has a consensus rating of “Hold” and an average price target of $28.63.
Shares of Imax (NYSE:IMAX) opened at $21.15 on Friday. Imax has a fifty-two week low of $17.58 and a fifty-two week high of $34.60. The firm has a market capitalization of $1,372.68, a P/E ratio of 528.88, a PEG ratio of 1.58 and a beta of 0.82.
In other news, CFO Patrick Mcclymont sold 2,811 shares of the stock in a transaction that occurred on Thursday, March 8th. The stock was sold at an average price of $20.40, for a total value of $57,344.40. Following the sale, the chief financial officer now directly owns 2,145 shares in the company, valued at $43,758. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, CEO Greg Foster sold 4,889 shares of the stock in a transaction that occurred on Thursday, March 8th. The stock was sold at an average price of $20.40, for a total value of $99,735.60. Following the completion of the sale, the chief executive officer now owns 77,604 shares in the company, valued at $1,583,121.60. The disclosure for this sale can be found here. Over the last quarter, insiders sold 24,131 shares of company stock worth $501,243. Company insiders own 18.90% of the company’s stock.
TRADEMARK VIOLATION WARNING: This article was originally reported by The Ledger Gazette and is the property of of The Ledger Gazette. If you are viewing this article on another website, it was stolen and republished in violation of U.S. & international trademark and copyright laws. The correct version of this article can be accessed at https://ledgergazette.com/2018/03/16/imax-imax-getting-somewhat-positive-media-coverage-study-finds.html.
Imax Company Profile
IMAX Corporation is an entertainment technology company. The Company operates through seven segments: IMAX systems; theater system maintenance; joint revenue sharing arrangements; film production and IMAX DMR; film distribution; film post-production, and other. The IMAX systems segment designs, manufactures, sells or leases IMAX theater projection system equipment.
Receive News & Ratings for Imax Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imax and related companies with MarketBeat.com's FREE daily email newsletter.